Anastrozole

@article{Sanford2012Anastrozole,
  title={Anastrozole},
  author={Mark Sanford and Greg L. Plosker},
  journal={Drugs},
  year={2012},
  volume={68},
  pages={1319-1340}
}
Anastrozole (Arimidex®) is an aromatase inhibitor approved in the EU, the US and in other countries worldwide for use as an adjuvant treatment in postmenopausal women with early-stage, hormone receptor-positive breast cancer. It is also approved in the EU and other countries worldwide for continuing adjuvant treatment in women who have already had 2–3 years… CONTINUE READING